124 related articles for article (PubMed ID: 4419530)
1. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review.
Schwallie PC; Assenzo JR
Contraception; 1974 Aug; 10(2):181-202. PubMed ID: 4419530
[No Abstract] [Full Text] [Related]
2. [Blood levels of megestrol acetate following injection of the microencapsulated compound megestrol acetate and its effect on pituitary-ovarian function].
Xu LZ; Han ZY; Yue YC; Yang SZ
Hua Xi Yi Ke Da Xue Xue Bao; 1988 Mar; 19(1):97-101. PubMed ID: 3391610
[No Abstract] [Full Text] [Related]
3. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
[TBL] [Abstract][Full Text] [Related]
4. Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses.
Bassol S; Garza-Flores J; Cravioto MC; Diaz-Sanchez V; Fotherby K; Lichtenberg R; Perez-Palacios G
Fertil Steril; 1984 Aug; 42(2):216-22. PubMed ID: 6235131
[TBL] [Abstract][Full Text] [Related]
5. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
6. Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera).
Kirton KT; Cornette JC
Contraception; 1974 Jul; 10(1):39-45. PubMed ID: 4442263
[No Abstract] [Full Text] [Related]
7. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
8. Injectable medroxyprogesterone acetate contraception: metabolic and endocrine effects.
Vecchio TJ
J Reprod Med; 1973 Apr; 10(4):193-6. PubMed ID: 4695501
[No Abstract] [Full Text] [Related]
9. Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women.
Jeppsson S; Johansson
Contraception; 1976 Oct; 14(4):461-69. PubMed ID: 975831
[No Abstract] [Full Text] [Related]
10. STUDIES ON PITUITARY, ADRENOCORTICAL, AND OVARIAN FUNCTION DURING TREATMENT WITH MEDROXYPROGESTERONE ACETATE.
FUCHS F; JOHNSEN SG; MOELLER KJ
Int J Fertil; 1964; 9():147-50. PubMed ID: 14106248
[No Abstract] [Full Text] [Related]
11. A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.
Fotherby K; Saxena BN; Shrimanker K; Hingorani V; Takker D; Diczfalusy E; Landgren BM
Fertil Steril; 1980 Aug; 34(2):131-9. PubMed ID: 7409232
[TBL] [Abstract][Full Text] [Related]
12. Long-acting injectable contraceptives.
Vecchio TJ
Adv Steroid Biochem Pharmacol; 1976; 5():1-64. PubMed ID: 779431
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ovulation by intracranial implants of medroxyprogesterone acetate.
Malven PV; Ruiz-Diaz R
J Anim Sci; 1971 May; 32(5):919-21. PubMed ID: 5571585
[No Abstract] [Full Text] [Related]
14. Mechanism of action of medroxyprogesterone (17-alpha-acetoxy-6-alpha-methyl progesterone) in the rat.
Labhsetwar AP
J Reprod Fertil; 1966 Dec; 12(3):445-51. PubMed ID: 5928266
[No Abstract] [Full Text] [Related]
15. [Action of medroxyprogesterone (Provera) on the pituitary gland, mammary glands and ovaries of the female rat].
Ectors F; Pasteels JL; Herlant M
C R Acad Hebd Seances Acad Sci D; 1966 Dec; 263(25):1988-91. PubMed ID: 4963932
[No Abstract] [Full Text] [Related]
16. The effect of medroxyprogesterone on cells of the pituitary pars distalis.
Baker BL; Eskin TA; Clapp HW
Proc Soc Exp Biol Med; 1972 May; 140(1):357-61. PubMed ID: 4338185
[No Abstract] [Full Text] [Related]
17. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent.
Jeppsson S
Acta Obstet Gynecol Scand; 1972; 51(3):257-63. PubMed ID: 5072161
[No Abstract] [Full Text] [Related]
18. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
19. The effect of medroxyprogesterone acetate (Provera) on ovarian radiosensitivity.
Jarrell J; YoungLai EV; McMahon A; Barr R; O'Connell G; Belbec L
Am J Obstet Gynecol; 1989 Apr; 160(4):990-4. PubMed ID: 2523668
[TBL] [Abstract][Full Text] [Related]
20. Canine reproduction: effects of a single injection of medroxyprogesterone acetate on the reproductive organs of intact and ovariectomized bitches.
Sokolowski JH; Zimbelman RG
Am J Vet Res; 1973 Dec; 34(12):1501-3. PubMed ID: 4762717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
